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Primary cultures of gilthead sea bream myocytes were performed in order to examine the
relative metabolic function of insulin compared with IGF-I and IGF-II (insulin-like growth fac-
tors, IGFs) at different stages in the cell culture. In these cells, the in vitro effects of insulin
and IGFs on 2-deoxyglucose (2-DG) and L-alanine uptake were studied in both myocytes
(day 4) and small myotubes (day 9). 2-DG uptake in gilthead sea bream muscle cells was
increased in the presence of insulin and IGFs in a time dependent manner and along with
muscle cell differentiation. On the contrary, L-alanine uptake was also stimulated by insulin
and IGFs but showed an inverse pattern, being the uptake higher in small myocytes than in
large myotubes. The results of preincubation with inhibitors (PD-98059, wortmannin, and
cytochalasin B) on 2-DG uptake indicated that insulin and IGFs stimulate glucose uptake
through the same mechanisms, and evidenced that mitogenesis activator protein kinase
(MAPK) and PI3K–Akt transduction pathways mediate the metabolic function of these pep-
tides. In the same way, we observed that GLUT4 protein synthesis was stimulated in the
presence of insulin and IGFs in gilthead sea bream muscle cells in a different manner at
days 4 or 9 of the culture. In summary we describe here, for the ﬁrst time, the effects of
insulin and IGFs on 2-DG and L-alanine uptake in primary culture of gilthead sea bream
muscle cells. We show that both MAPK and PI3K–Akt transduction pathways are needed
in order to control insulin and IGFs actions in these cells. Moreover, changes in glucose
uptake can be explained by the action of the GLUT4 transporter, which is stimulated in the
presence of insulin and IGFs throughout the cell culture.
Keywords: insulin, insulin-like growth factors I and II, glucose and amino acid metabolism, muscle, sea bream,
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INTRODUCTION
The farming of gilthead sea bream, Sparus aurata, is one of the
most important aquaculture industries in the Mediterranean area
(FAO, 2009). In addition to the social and economic beneﬁts that
the development of aquaculture supposes worldwide, research to
improve ﬁsh growth and development, especially in commercial
species, is still missing. In order to do so, we believe that strategies
that help us to understand the nutritional and endocrine regu-
lation of ﬁsh growth are needed. On the other hand, taking into
account that muscle in ﬁsh can account for more than 50% of
the weight of an adult individual, and that muscle growth will
determine the ﬁnal size of the animal, the adoption of practices
to manipulate ﬁsh growth are conditioned to the understand-
ing of muscle growth regulating processes (reviewed by Johnston
et al., 2011). Although recent advances have been made in terms
of nutritional and environmental regulation of muscle forma-
tion, mostly in salmonids (Rescan et al., 1995; Johnston et al.,
2011), data at the molecular and cellular level are scarce. The use
of in vitro tools has recently allowed advancing in this matter.
Therefore, in the present work we took advantage of using pri-
mary cultures of muscle satellite cells in order to study the role
of insulin and the insulin-like growth factors (IGFs) in sea bream
metabolism.
Cultures of muscle satellite cells as a model system to study
muscle growth have been developed for different ﬁsh species (Fau-
conneau and Paboeuf, 2000; Castillo et al., 2002; Montserrat et al.,
2007a), but in vitro, these satellite cells only differentiated to large
myotubes for the studies undertaken on Oncorhynchus mykiss by
some authors (Rescan et al., 1994, 1995; Fauconneau and Paboeuf,
1998). Our group described, for the ﬁrst time, that the IGF system
is implicated in both proliferation and differentiation processes,
as well as in the regulation of the metabolic functions in cultured
trout satellite muscle cells (Castillo et al., 2004; Codina et al., 2008)
as reported previously in mammals (Beguinot et al., 1985; Ewton
et al., 1994; Ciaraldi et al., 2001). The important role of the growth
hormone (GH)/IGF-I axis coordinating postnatal skeletal muscle
expansion and differentiation during early development has been
clearly demonstrated both in ﬁsh (Reinecke et al., 2005) and in
mammals (Florini et al., 1996). In mouse transgenic lines lacking
IGF-I (and/or its receptor) embryonic development is impaired,
resulting in a reduced growth in these animals (Florini et al., 1996).
On theotherhand, transgenicmiceoverexpressingGHhave shown
a dramatic two-fold growth enhancement (Ahrens and Devlin,
2011). Similarly, regarding ﬁsh, many species, and strains have
been shown to be capable of being greatly growth stimulated either
by using GH treatment or transgenesis, domestication, or selective
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breeding (Ahrens and Devlin, 2011). The accumulated evidence
to date, suggests, that the major components of the IGF signaling
system are also implicated in the growth of gilthead sea bream.
During the past decades, in vivo studies on protein/energy ratio
have shown the nutritional regulation of the IGF-I axis in gilt-
head sea bream (reviewed by Pérez-Sánchez and Le Bail, 1999).
In the same scenario, other authors showed a positive correla-
tion between IGF-I plasmatic values and changes in ration size in
this species (Pérez-Sánchez et al., 1995; Marti-Palanca et al., 1996;
Company et al., 1999). Lately, it has been demonstrated the role of
GH and IGF-I on seasonal growth and the effect of diets with plant
protein supply on nitrogen-metabolism and GH-liver axis (Min-
garro et al., 2002; Gómez-Requeni et al., 2003, 2004). Importantly,
our group recently described the role of insulin and IGF-I during
the compensatory growth of the sea bream demonstrating their
distinct actions in response to the nutritional status (Montserrat
et al., 2007b).
Besides the growth actions of IGF-I, it has been demonstrated
that both insulin and IGF-I play a critical role in the regulation
of ﬁsh metabolism. Several studies in ﬁsh reported the action
of insulin and IGF-I on glucose and amino acid uptake in dis-
tinct cell tissues (Inui and Ishioka, 1983; Negatu and Meier, 1995;
Soengas and Moon, 1995, 1998; Gallardo et al., 2001; Navarro
et al., 2003; Capilla et al., 2004; Castillo et al., 2004; Codina et al.,
2008; Bouraoui et al., 2010). Moreover, Vega-Rubín de Celis et al.
(2004) observed increases in glucose, glucagon, and insulin plasma
levels when arginine was injected intraperitoneally on gilthead
sea bream, demonstrating the interactions between amino acid
metabolism and glucose homeostasis in this species. Interestingly,
in our group, Rojas et al. (2004) partially cloned a speciﬁc glucose
transporter (saGLUT4) from red muscle of gilthead sea bream,
describing the effects of different experimental diets on its expres-
sion, and described that intraperitoneal administration of arginine
on gilthead sea bream provoked increases in the levels of GLUT4
protein in white skeletal muscle.
Overall, all these data evidence the important role for insulin
and IGFs in gilthead sea bream skeletal muscle physiology and
homeostasis. However, we believe that all those ﬁndings remain
to be analyzed in detail. In order to ﬁnally understand the role
of the IGF system in muscle growth and development we used
a primary culture of gilthead sea bream muscle cells previously
described (Montserrat et al., 2007a). The aim of this study was to
analyze the role of IGFs onmetabolic processes such as glucose and
amino acid uptake compared to insulin, and to identify the main
signaling pathways undertaken by the IGF-I receptor by using spe-
ciﬁc inhibitors in gilthead sea bream muscle cells. Besides, we have
detected stimulation of GLUT4 protein expression in those cells in
the presence of the different peptides throughout the cell culture.
MATERIALS AND METHODS
CHEMICALS
2-Deoxy-D-[2, 6-3H] glucose with a speciﬁc activity of
43Ci/mmol and L-[2, 3-3H] alanine with a speciﬁc activity of
52Ci/mmol were purchased from Amersham Pharmacia Biotech
Europe (Barcelona, Spain). Recombinant human IGF-I and IGF-II
were purchased from Peninsula Laboratories Europe (Merseyside,
UK). Anti-phospho-p44/42 (cat no 9106), anti-Akt (cat no 9272),
anti-Akt-P (cat no 9271), and anti-p44/42 (cat no 4696) antibodies
were ordered from Cell Signaling Technology Inc. (Beberly, MA,
USA). All the remaining reagents were purchased from Sigma-
Aldrich Química S.A. (Madrid, Spain). The okGLUT4 (against
GLUT4 from coho salmon, Oncorhynchus kisutch) antibody was a
kind gift from Dr. Josep Planas (University of Barcelona) and has
been previously well characterized (Capilla et al., 2004).
ANIMALS AND CELL CULTURE
We used gilthead sea breams (Sparus aurata) with weights ranging
from 2.8 to 8.5 g. Animals were provided by Aquamar S.L. (San
Fernando, Cádiz, Spain). Fish were maintained in facilities at the
Faculty of Biology (Barcelona) in closed-circuit ﬂow systems at
19˚C, fed ad libitum with a commercial diet, and fasted for 24 h
before the experiments. The ﬁsh (70–80 for each culture) were
killed by a sharp blow to the head, weighted, and immersed in
70% ethanol for 30 s to sterilize external surfaces.
The procedure for the isolation of the satellite cells was per-
formed following the protocol previously described for gilthead
sea bream by Montserrat et al. (2007a). All experiments were
conducted with cells seeded at a density of 2× 106 cells per
well in six-well plastic plates (9.6 cm2/well, NUNC). Observa-
tions on morphology were regularly made to control the state
of the cells, which were used at day 4/5 (myocytes and recently dif-
ferentiated myotubes) and at day 9 (mostly small myotubes) for
2-deoxyglucose (2-DG) and l-alanine uptake assays and Western
blotting. All experiments were performed three times; each condi-
tion was performed in triplicate (three wells). Cells were incubated
at 21˚C, the optimal temperature for growth of the culture.
L-ALANINE UPTAKE ASSAY
For l-alanine uptake assays, after 4 or 9 days of culture, the
medium (90% Dulbecco’s modiﬁed eagle medium+ 10% fetal
bovine serum, DMEM–FBS) was aspirated and the cells were
rinsed with ice-cold phosphate buffer saline (PBS) and main-
tained in DMEM+ 0.5% bovine serum albumin (DMEM–BSA)
without FBS for 2–3 h.After preincubationwithDMEM–BSAcon-
taining different concentrations of peptides (from 10 to 100 nM
for IGF-I or IGF-II and 100 nM to 1μM for insulin) at differ-
ent times (1 or 2 h), the medium was aspirated, rinsed two times
with ice-cold PBS, and the cells were incubated with 1 μCi/ml of
l-alanine for 20min. Previously, time course experiments were
performed to ﬁnd the best conditions for the study (data not
shown). The amino acid uptake was stopped by aspiration of the
supernatant, followed by three rapid washes with ice-cold PBS.
Next, cells were solubilized with NaOH 0.1N. Finally, the sam-
ples were placed in scintillation vials, and the radioactivity was
counted with a TRICARB 2100 β-counter (Packard Bioscience,
Meriden, CT, USA).
2-DG UPTAKE ASSAYS
For 2-DG assays, the cells after 4 or 9 days of culture, were incu-
bated for 4 h with DMEM–BSA without FBS and after this period
pre-incubated (30 or 60min) in the presence or absence of insulin
(1μM), IGF-I (100 nM), or IGF-II (100 nM) in DMEM–BSA.
After preincubation, the cells were rinsed two times with ice-
cold PBS and incubated with unlabeled 50μM 2-DG together
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with labeled 2-DG (2μCi/ml) in HEPES-saline buffer. The incu-
bations with labeled and cold 2-DG, except for the time course
experiments, were routinely of 30min. The contents of the wells
were aspirated and rinsed three times with ice-cold PBS, and
the cells were lysed with NaOH 0.5N. The contents of the wells
were removed and placed into scintillation vials, and the radioac-
tivity was quantiﬁed with a TRICARB 2100 β-counter (Packard
Bioscience, Meriden, CT, USA).
In order to better characterize glucose transport the effects of
several compounds on glucose uptake stimulation by insulin and
IGFs were analyzed at day 5 in the cell culture. PD-98059 is an
inhibitor of the MEK1 protein, a component of the mitogene-
sis activator protein kinase (MAPK) pathway; wortmannin is an
inhibitor of the PI3K–Akt pathway; and cytochalasin B is a spe-
ciﬁc inhibitor of the facilitative glucose transporters. Cells were
pre-incubated for 30min with wortmannin (1μM) or PD-98059
(50μM),andpeptides (IGF-I, IGF-II,or insulin)were added for 30
additional min. The cytochalasin B (20μM) was added and incu-
bated simultaneously with the labeled 2-DG for 30min. Doses of
inhibitors were selected from previous results obtained in similar
experiments by Castillo et al. (2004).
WESTERN BLOT ANALYSIS
In order to characterize the signal transduction pathways, follow-
ing 4 days in culture, the cellswere incubatedwithDMEM–BSA for
2–3 h. Next, cells were pre-incubated for 30min with wortmannin
(1μM) or PD-98059 (50 μM). Afterward, cells were stimulated in
the presence of a ﬁxed concentration of peptides (100 nM for IGF-I
and IGF-II or 1μMfor insulin) for 30minwithDMEM–BSA. Sub-
sequently, the medium was aspirated, the wells were washed with
ice-cold PBS, and the cells were lysed with lysis buffer (1% NP-40,
0.4mM sodium orthovanadate, 10mM Tris, 140mM NaCl, 5mM
EDTA, 50mM NaF, 1mM PMSF, 10μg/ml Aprotinin, 10μg/ml
Leupeptin, pH 7.6). After obtaining the cell lysates, protein con-
tent was determined with the Bradford reagent method (Bradford,
1976) and electrophoresis using a polyacrylamide gel was con-
ducted in the presence of SDS (SDS-PAGE; each lane loaded with
30μg of protein). Samples were then transferred to a PVDF mem-
brane for 90min under a constant current of 1A in a transfer
buffer (25mM Tris–HCl, 190mM Glycine, 20% Methanol, pH
7.5). Following a 30min wash (10mM Tris–HCl, 100mM NaCl,
0.1% Tween 20, pH 7.5) the membrane was incubated for 1 h
at room temperature with the primary antibody (at 1:500 dilu-
tion). The primary antibodies detected the presence of MAPK
and its active form (MAPK-P), as well as the Akt protein and its
phosphorylated form (Akt-P).
Lysates of cells at day 4 and day 9, stimulated with 100 nM
IGF-I or IGF-II or 1μM insulin for 1 h were performed for the
detection of GLUT4. Immunoblots were performed using the
okGLUT4 antibody at 1:500 dilution in Tris-buffered saline con-
taining 0.1% Tween 20 and 5% non-fat dry milk for 2 h at room
temperature. The secondary antibody was used at 1:5000 dilution
in the same buffer, and the detection of the luminescence was done
using an enhanced chemiluminescence kit (Amersham,Barcelona,
Spain). After developing with an automated ﬁlm processor, the x-
ray ﬁlms from three independent experiments were scanned and
the intensity of the bands evaluated using the software TotalLab.
FIGURE 1 | Stimulation of L-alanine uptake by insulin, IGF-I, and IGF-II
in sea bream myocytes. Cells at day 4 of in vitro development were
incubated for 2 h with IGF-I or IGF-II (both at 100 nM) or insulin (1μM), and
subsequently incubated with labeled L-alanine for 20 additional min.
Results are expressed as percentage of stimulation above basal levels and
mean±SE (n=3 experiments). Statistical differences between conditions
were analyzed by one-way ANOVA followed byTukey’s post hoc test.
Different letters indicate signiﬁcantly (P <0.05) different values among
groups.
STATISTICAL ANALYSIS
The different treatments were performed in triplicate for each
experiment. Data are presented as means± SE of at least three
independent experiments. Statistical differences between condi-
tions in Figures 1, 2 and 4 were analyzed by one-way analysis
of variance (ANOVA) followed by the Tukey’s post hoc test; and
by two-ways ANOVA for the data presented in Table 1 regarding
the signaling pathways activities. In Figure 3 statistical differences
between inhibitors treatments within each hormonal condition
were analyzed by one-way ANOVA followed by Tukey’s post hoc
test; and also, statistical differences between hormonal treatments
in basal conditionswere analyzed by another one-wayANOVAand
the Tukey’s post hoc test. In all cases, differences were considered
statistically signiﬁcant at P < 0.05.
RESULTS
IGF-I, IGF-II, AND INSULIN EFFECTS ON L-ALANINE UPTAKE
The effects of IGF-I, IGF-II, and insulin on alanine uptake were
analyzed at day 4 in the cell culture. As shown in Figure 1, all
the tested peptides signiﬁcantly stimulated alanine uptake over
the basal values. IGF-I and IGF-II showed higher stimulation of
alanine uptake when compared to insulin, also considering that
IGF-I and IGF-II concentration was 10 times lower than that of
insulin.
When the same experiment was carried out in cells at day 9
of the culture (myotubes), the same tendency was observed, but
both, the basal and stimulated alanine uptake levels were clearly
lower than those found in myocytes at 4 days of culture (data not
shown).
IGF-I, IGF-II, AND INSULIN EFFECTS ON 2-DG UPTAKE
Figure 2A shows the effects of IGF-I and IGF-II compared with
insulin on glucose uptake on muscle cells at day 4. The preincu-
bation of the cells with the peptides extended for 30 or 60min,
and glucose uptake was ﬁxed at 30min. In general, preincubating
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FIGURE 2 | Effect of insulin, IGF-I, and IGF-II on 2-deoxyglucose uptake
in sea bream muscle cells. Cells were isolated and cultured for 4 days to
have myocytes (A) or 9 days to obtain small myotubes (B) and incubated
with the peptides, IGF-I or IGF-II (both at 100 nM) or insulin (1μM) for 30 or
60min, and subsequently incubated with labeled 2-deoxyglucose (2-DG) for
30 additional min. Results are expressed as percentage of stimulation
above basal levels and means±SE (n=3 experiments). Statistical
differences between conditions were analyzed by one-way ANOVA
followed byTukey’s post hoc test. Different letters indicate signiﬁcantly
(P <0.05) different values among groups.
the cells during 60min in the presence of the different peptides
resulted in higher stimulatory effects on glucose uptake. IGF-I
and IGF-II showed higher stimulation of glucose uptake when
comparing to insulin effects.
As shown in Figure 2B, the same experiments were performed
at day 9 of the cell culture, and the stimulatory effects of both
IGF-I and IGF-II were again higher than those exerted by insulin
after either 30 or 60min of incubation.
The effects of the different inhibitors on glucose uptake stim-
ulated by IGF-I, IGF-II, and insulin on day 5 myocytes are shown
FIGURE 3 | Effect of inhibitors on 2-deoxyglucose uptake in sea bream
myocytes. Cells at day 5 were pre-incubated for 30min with wortmannin
(W, 1μM) or PD-98059 (PD, 50μM). Next, IGF-I or IGF-II (both at 100 nM) or
insulin (1μM) were added for 30 additional min. Cytochalasin B (CK, 20μM)
was incubated for 30min. Results are expressed as percentage of
stimulation over basal levels and mean±SE (n=3 experiments). Statistical
differences between inhibitors treatments within each hormonal condition
were analyzed by one-way ANOVA followed byTukey’s post hoc test.
Different letters indicate signiﬁcantly (P <0.05) different values among
inhibitors treatments (different letters have been used for each hormonal
group). Also, statistical differences between hormonal treatments in basal
conditions were analyzed by one-way ANOVA followed byTukey’s post hoc
test and are indicated with a different number of asterisks when P <0.05.
in Figure 3. Both PD-98059 and in a higher degree wortmannin,
signiﬁcantly inhibited the basal glucose uptake and the stimula-
tory effects of IGF-I, IGF-II, and insulin. The same results were
found when the cells were incubated in the presence of the glucose
transporter inhibitor, cytochalasin B.
INHIBITION OF Akt AND MAPK SIGNALING PATHWAYS
The effects of the speciﬁc inhibitors from both signaling pathways
on day 4 cells are shown in Table 1. Preincubation of the cells with
wortmannin (inhibitor of the Akt signaling pathway) reduced the
IGF-I and IGF-II stimulated phosphorylation of Akt protein (from
237 to 67% and 345 to 56% above basal values, respectively). The
effect of PD-98059 (inhibitor of the MAPK signaling pathway)
reduced the effects of both IGF-I and IGF-II on MAPK phospho-
rylation (from 146 to 34% and 231 to 45%, respectively). Neither
of the inhibitors had any crossed effect on the other pathway.
IMMUNODETECTION OF GLUT4
With the use of an anti-okGLUT4 polyclonal antibody, a band of
approximately 50 kDa was detected at day 4 and day 9 sea bream
muscle cells (Figure 4). Speciﬁcity of the 50-kDa band was con-
ﬁrmed by the use of preimmune serum (data not shown). At
day 4 the incubation of myocytes with 1μM insulin for 30min
resulted in GLUT4 stimulation (50% above basal levels), whereas
no changes of GLUT4 protein expression were observed when
these cells were incubated neither with IGF-I nor IGF-II (100 nM).
When myotubes of day 9 were incubated with 100 nM IGF-I
or IGF-II for 30min, GLUT4 protein expression was increased
∼200% above basal levels. The incubation with 1μM insulin did
not cause a signiﬁcant stimulatory effect on GLUT4 protein levels
at this time as that caused by the IGFs.
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FIGURE 4 | GLUT4 levels in gilthead sea bream muscle cells during
development. (A) Myocytes (day 4) and (B) small myotubes (day 9)
were incubated with insulin (1μM), IGF-I, or IGF-II (both at 100 nM) for
60min and subsequently lysed. Thirty micro gram of protein were
loaded in each lane and subjected to 10% SDS-PAGE under reducing
conditions.Western blot was performed with a primary antibody
against GLUT4 (ﬁnal dilution 1:500) and a secondary antibody
anti-rabbit (1:5000). Results are expressed as percentage of band
intensity above basal and mean±SE (n=3 experiments). Statistical
differences between conditions were analyzed by one-way ANOVA
followed byTukey’s post hoc test. Different letters indicate signiﬁcantly
(P <0.05) different values among groups.
Table 1 | Effect of inhibitors on the MAPK and PI3K–Akt pathways in IGF-I or IGF-II treated sea bream myocytes.
No treatment (%) IGF-I 100nM (%) IGF-I 100nM+
W (1μM; %)
IGF-I 100nM+
PD (50μM; %)
IGF-II 100nM (%) IGF-II 100nM+
W (1μM; %)
IGF-II 100nM+
PD (50μM; %)
MAPK-P 100a 146±23b 123±29c 34±4d 231±19e 187±17f 45±19d
Akt-P 100a 237±17b 67±17c 212±17d 345±17e 56±9c 314±19f
Cells at day 4 of in vitro development were pre-incubated for 30min with inhibitors: wortmannin (W, 1μM) or PD-98059 (PD, 50μM). Then, IGF-I or IGF-II (both at
100 nM) were added for 30 additional min. Results are expressed as percentage of stimulation above basal levels and means±SE (n=3 experiments). Statistical
differences between conditions were analyzed by two-ways ANOVA analyzing each signaling pathway separately. Different letters indicate signiﬁcantly (P<0.05)
different values among groups.
DISCUSSION
This study is the ﬁrst report on the metabolic effects of insulin
and IGFs on cultured gilthead sea bream myocytes. Although the
implication of insulin and IGF-I in growth processes have been
reported in this species in vivo, the lack of information regarding
the role of these peptides on sea bream muscle metabolism led us
to examine the insulin and IGFs-stimulated uptake of metabolic
substrates (2-DG and l-alanine). The use of speciﬁc inhibitors of
the main signaling pathways conﬁrmed that MAPK and PI3K–
Akt pathways are implicated in glucose metabolism in gilthead sea
bream cultured muscle cells. On the other hand, the inhibitory
effect of cytochalasin B on insulin and IGFs 2-DG stimulation,
together with the detection of a GLUT4 transporter in sea bream
myocytes, reveals the role of the studied peptides on sea bream
glucose metabolism.
Muscle growth dynamics in ﬁsh results in large part from stim-
ulation of protein synthesis, which directly depends on amino
acids availability (Brodeur et al., 2003). Our data clearly showed
that both IGF-I and IGF-II are more effective than insulin in stim-
ulating l-alanine uptake at day 4 myocytes. Previous work has
demonstrated the stimulatory effects on amino acid uptake of
insulin and IGF-I, respectively, in ﬁsh muscle (Inui and Ishioka,
1983; Negatu and Meier, 1995). More recently, higher stimulatory
effects for IGF-I than for insulin have been demonstrated in trout
isolated cardiomyocytes (Gallardo et al., 2001) and on cultured
rainbow trout myocytes (Castillo et al., 2004). However, the stim-
ulatory effect of the peptides on l-alanine uptake in our study, is
more effective in early stages of the cell culture (day 4) than at day
9. These data support the idea that amino acid requirement seems
to be more important during proliferative stages than during cell
muscle development (Castillo et al., 2004).
Fish are generally thought to have a limited ability to utilize
carbohydrate when compared to mammals (Legate et al., 2001).
The skeletal muscle is the main tissue responsible for eliminating
plasma glucose in brown trout after a glucose load (Blasco et al.,
1996). In the current study we investigated the role of IGF-I and
IGF-II compared with insulin, in the 2-DG uptake in sea bream
myocytes.
The present data showed that IGFs are more effective than
insulin in stimulating glucose uptake in both myocytes and large
myotubes; however, the stimulation increased along muscle cells
differentiation in vitro. Previous studies in cultured rainbow trout
myocytes showed similar results (Castillo et al., 2004), but no data
was available to date in gilthead sea bream muscle cells. Recently,
Navarro et al. (2003) and Bouraoui et al. (2010) demonstrated
also that IGF-I had higher stimulatory effects than insulin in 2-
DG uptake in isolated sea bream adipocytes and primary culture
of trout adipocytes, respectively. In the same way, previous work in
mammals showed that IGF-I and IGF-II stimulated 2-DG uptake
in rat and human muscle cells (Beguinot et al., 1985; Bevan et al.,
1992; Zierath et al., 1992). Although the type II IGF-receptor has
been identiﬁed in brown trout by our group (Méndez et al., 2001),
studies in mammalian cells based on ligand competition (Ewton
et al., 1987), IGF-II analogs (Burguera et al., 1994), and the use of
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an antibody to the type II IGF-receptor (Kiess et al., 1987), have
suggested that the biological effects of both IGFs are mediated by
the type I IGF-receptor.
Results in this study, have demonstrated that both IGF-I and
IGF-II had higher stimulatory effects on 2-DGglucose uptake than
those described by Castillo et al. (2004) and Codina et al. (2008)
in rainbow trout myocytes at similar concentrations of peptides.
Increases in absolute 2-DG uptake stimulation by IGFs through-
out the cell culture might be related to the reported increase in
IGF-I receptor levels, as well as to the higher metabolic needs
in differentiated myotubes than in myocytes (Montserrat et al.,
2007a).
In order to determine the speciﬁcity underlying the glucose
uptake process, we incubated day 5 sea bream myocytes in the
presence of PD-98059 and wortmannin. In agreement with the
observations of Castillo et al. (2004) in rainbow trout myocytes,
we found out a decrease on insulin and IGFs 2-DG stimulation,
which indicates that both, MAPK and PI3K–Akt pathways are
implicated in glucose metabolism in ﬁsh muscle. In addition, the
use of cytochalasin B blocked the stimulatory effects of insulin and
IGFs, suggesting that glucose transport takes place thought speciﬁc
facilitative transporters in sea bream cultured myocytes. Previous
studies on ﬁsh reported the existence of cytochalasin B-sensitive
glucose transport in red blood cells of the eel (Tse and Young,
1990; Soengas andMoon, 1995) the primitive hagﬁsh (Young et al.,
1994) and in the black bullhead (Soengas and Moon, 1998). More
recently, 2-DG uptake was inhibited by cytochalasin B in Xenopus
laevis oocytes expressing an insulin-responsive glucose transporter
(GLUT4) cloned from salmon (okGLUT4; Capilla et al., 2004).
These previous ﬁndings led us to check the presence of the speciﬁc
GLUT4 transporter in sea bream myocytes. In the present study,
GLUT4 protein synthesis was stimulated by IGFs and insulin in a
different manner throughout the cell culture. In mammals, sev-
eral studies reported the stimulation of IGF-II in GLUT4 protein
synthesis (Kaliman et al., 1996), as well as the effects of insulin on
GLUT4 transcription in human muscle cell cultures (Al-Khalili
et al., 2003). Similarly, an insulin injection in vivo was shown to
induce an increase in GLUT4 mRNA expression and protein con-
tent in trout muscle (Capilla et al., 2002; Diaz et al., 2007). Current
efforts in our laboratory are underway to examine whether insulin
and IGFs stimulate the protein synthesis of GLUT4 in gilthead sea
bream muscle cells.
On the other hand, it has been widely described in mam-
mals that acute insulin treatment stimulates glucose transport in
adipocytes and myocytes, largely by mediating translocation of
GLUT4 from an intracellular compartment to the plasma mem-
brane, as reviewed by Pessin and Saltiel (2000). In the same way,
the effects of IGF-I in 2-DG uptake on L6 cells overexpressing
the GLUT4 transporter where higher than in wild type L6 cells
(Lawrence et al., 1992). More recently, also in L6 muscle cells, the
stimulatory effects of a glutamate receptor agonist (homocysteine
sulﬁnic acid) on 2-DG uptake and GLUT4 translocation have been
reported (Kim et al., 2011).
Previous ﬁndings in our group showed the stimulatory effects
of insulin and IGFs on Akt phosphorylation in cultured sea bream
myocytes (Montserrat et al., 2007a). The present work suggested
that such an increase in Akt phosphorylation throughout the cell
culture could be related to the observed increase of GLUT4 protein
content after insulin and IGFs incubations, and this observation
is also supported by the inhibitors (wortmannin and cytochalasin
B) results. In fact, studies in a number of cell types including
myocyte, myotubes, and adipocytes, related GLUT4 translocation
to the plasma membrane with PI3K promotion of Akt phosphory-
lation (Wilson et al., 1995; Zorzano et al., 2000; Saltiel and Kahn,
2001; Rauch and Loughna, 2005). In the same way, it has been
shown that expression of either constitutively active PI3K (Teng-
holm and Meyer, 2002) or Akt (Kohn et al., 1996) is sufﬁcient to
stimulate GLUT4 translocation and insertion to the plasma mem-
brane to an extent comparable to that observed with insulin alone.
Thus, the increase in the insulin-IGFs-stimulated increment in 2-
DG uptake in sea bream myocytes, may be in part explained by
either enhanced insulin-IGFs-stimulated GLUT4 protein synthe-
sis, or translocation of the transporter to the membrane through
the PI3K–Akt phosphorylation reported in this study.
In conclusion, stimulatory effects of both, IGF-I and IGF-II
on l-alanine uptake were higher than those found by insulin in
day 4 sea bream muscle cells, and this stimulatory effect decreased
with cell differentiation. In the same way, again both IGFs exerted
higher stimulatory effects than insulin in 2-DG uptake, being
more remarkable at day 9 myotubes. The stimulatory effects from
both IGF-I and IGF-II in 2-DG uptake in differentiated myotubes,
together with the stimulation of GLUT4 protein content, reveals
the important role of those peptides in ﬁsh glucose metabolism.
Interestingly, these ﬁndings showed for the ﬁrst time in this species
the metabolic role of IGF-II in sea bream muscle cells. Thus, our
in vitro sea bream myocyte cells culture system offers a suitable
model to further analyze the link between nutritional status and
skeletal muscle function in ﬁsh.
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